CD34 may be used to determine the adequacy of a stem cell harvest for hematologic recovery following high dose chemotherapy.
Zimmerman
T M
TM
University of Chicago, Illinois.
Lee
W J
WJ
Bender
J G
JG
Mick
R
R
Williams
S F
SF
D015703:Antigens, CD / Q000378:metabolism*; D018952:Antigens, CD34; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy / Q000628:therapy*; D002452:Cell Count; D003114:Colony-Forming Units Assay; D003131:Combined Modality Therapy; D005260:Female; D006098:Granulocytes; D006410:Hematopoiesis; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects* / Q000276:immunology*; D006801:Humans; D007958:Leukocyte Count; D010976:Platelet Count; D014182:Transplantation, Autologous
D015703:Antigens, CD; D018952:Antigens, CD34; D000970:Antineoplastic Agents